Imbio (a subsidiary of 4DMedical)

Minneapolis, United States  All United States companies → — Founded 2005
Imaging AI Specialist Specialty-Focused AI
Acquired

Products

Imbio PHA (4.0.0)
Imbio (a subsidiary of 4DMedical)
Cardiology AI
Imbio PHA (4.0.

See all 1 product →

About Imbio (a subsidiary of 4DMedical)

Imbio, a subsidiary of 4DMedical, is a healthcare AI company specializing in medical imaging solutions for chronic lung and cardiothoracic diseases. Their technology utilizes machine learning and AI to transform standard medical images, such as CT scans, into rich visual maps of a patient’s condition and quantitative reports. This provides physicians with detailed data on the type and extent of abnormalities, enabling data-based, personalized patient care from screening and diagnosis through procedure planning and therapy tracking.

Imbio’s automated systems are designed to integrate seamlessly into clinical workflows, delivering full quantitative analysis and 3D visualization without adding significant work for radiologists. Their algorithms support various clinical initiatives, including lung cancer screening, smoking cessation, surgical planning, and pulmonary embolism management. The company’s products aim to enhance diagnosis and disease staging, improve clinical efficiencies through automation, assist in drug and device development, and ultimately improve patient care through personalized medicine.

Following its acquisition by 4DMedical in December 2023, Imbio’s offerings are combined with 4DMedical’s functional lung analysis technology to provide a comprehensive cardiothoracic analysis software package. This combined approach offers functional, structural, and risk-based analysis for both lung and heart disease, aiming to revolutionize respiratory imaging and ventilation for improved lung disease detection and management.

Focus Areas

medical imaging analysis artificial intelligence machine learning chronic lung diseases cardiothoracic diseases pulmonary conditions lung cancer screening pulmonary embolism management COPD interstitial lung disease

Business Intelligence

TechnologyAI-powered medical imaging analysis, machine learning, cloud-based, web-based application, on-premise deployment

What Physicians Need to Know

Specialization
Imbio specializes in AI and machine learning-based medical imaging analysis, primarily focusing on chronic lung and cardiothoracic diseases. Their solutions transform standard medical images, particularly CT scans, into personalized medicine for improved patient discovery, diagnosis, treatment, and management.
Key Disease Areas
They offer algorithms and analysis for conditions such as COPD, emphysema, interstitial lung disease (ILD), pulmonary embolism, lung cancer screening, and cardiothoracic conditions.
Technology Stack
Imbio utilizes artificial intelligence, machine learning, deep learning, and advanced computer vision to analyze medical images. Their algorithms are designed to be fully automated and can be deployed via their Core Compute Platform (ICCP) on-premise, in the AWS cloud, or through partner platforms.
Key Differentiators
Imbio's solutions provide quantitative and personalized imaging analysis, transforming standard images into rich visual maps with detailed reports on abnormalities. They offer fully automated workflows that integrate seamlessly into existing systems, delivering results quickly without added work for physicians.
Product Examples
Their product portfolio includes Lung Density Analysis (LDAi, LDAf, LDA+), Lung Texture Analysis (LTA), Pulmonary Hypertension Assessment (PHA), Airway Analysis, and Coronary Calcification (CAC) analysis.
Acquisition by 4DMedical
In 2023, Imbio was acquired by 4DMedical, combining Imbio's anatomical and tissue analysis with 4DMedical's functional lung analysis (XV Technology® and CT LVAS™) to create a comprehensive cardiothoracic imaging solution.
Physician Tip

Imbio's AI-powered solutions act as a powerful tool in a physician's arsenal, not a replacement for their expertise. They enhance efficiency by automating image analysis, providing quantitative data and visual maps that can reveal subtle abnormalities difficult to detect with the human eye. This leads to more accurate diagnoses, personalized treatment plans, and improved patient management across various chronic lung and cardiothoracic conditions. The rapid, automated analysis allows for quicker insights, supporting initiatives like lung cancer screening and surgical planning.

Imbio's algorithms are designed for flexible deployment. They can run on Imbio's Core Compute Platform (ICCP) either fully on-premise within a hospital's firewall or via a secure bridge to their AWS cloud deployment. Additionally, Imbio partners with various platforms like Siemens syngo.via, Nuance, Aidoc, TeraRecon, FerrumHealth, and Flywheel, allowing institutions to integrate Imbio's dockerized algorithms into their existing AI platforms. The workflow is automated, receiving images via DICOM from scanners and returning results to PACS without altering normal procedures.

Products by Imbio (a subsidiary of 4DMedical)

1 product in the directory

Imbio PHA (4.0.0)
Imbio (a subsidiary of 4DMedical)
Cardiology AI
Imbio PHA (4.0.

Videos

News, demos, and interviews about Imbio (a subsidiary of 4DMedical).

Loading videos...

Videos load interactively. If none appear, search YouTube for Imbio (a subsidiary of 4DMedical) →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

Imbio offers a suite of AI-powered image analysis tools, including Lung Density Analysis (LDAi, LDAf, LDA+), Lung Texture Analysis (LTA), Pulmonary Hypertension Assessment (PHA), Airway Analysis, and Coronary Artery Calcification. These products assist in the diagnosis and management of conditions like COPD, emphysema, interstitial lung disease, and for use in lung cancer screening and surgical planning.
Imbio is HIPAA compliant, a certification achieved through Compliancy Group. Many of Imbio's products are regulatory cleared, including FDA 510(k) clearances for several algorithms, such as RV/LV Analysis. They also ensure data security and can integrate with existing hospital infrastructure like PACS.
Imbio's pricing model is subscription-based, with costs typically determined by the number of analyses performed or the number of installations. For specific pricing details, healthcare providers are encouraged to contact Imbio directly.
Imbio offers comprehensive customer support, including 24/7/365 technical support for all customers worldwide via phone, email, and online case submission. They also provide support for clinical questions regarding analysis output, portal support, billing, and general account inquiries.
Imbio has established various partnerships, including commercial collaborations with companies like Siemens Healthineers and MEDICAL-NOTE to expand global access to its AI algorithms. They also partner with leading medical researchers and physicians for product development and have collaborated with companies like Olympus for patient selection tools in emphysema treatment.
Imbio was acquired by 4DMedical in December 2023, creating a comprehensive cardiothoracic analysis software package. This acquisition enhances 4DMedical's offerings by combining Imbio's structural and tissue analysis with 4DMedical's functional lung imaging technology, aiming to provide a more complete solution for lung and heart disease detection and management.

Related Companies

Radin Health offers a comprehensive suite of AI-powered, cloud-based solutions designed to enhance operational efficiency across all stages of the radiology workflow. Their platform integrates a Radiology Information System (RIS), Picture Archiving and Communication System (PACS), AI-driven Dictation, and RADIN SELECT for workflow management. These solutions aim to improve efficiency and productivity for administrators, medical […]

Spectrum Dynamics Medical is a pioneering medical device company focused on transforming nuclear medicine from analog to digital technology. They specialize in developing high-definition, solid-state based nuclear imaging technology, including digital SPECT (Single Photon Emission Computed Tomography) and SPECT/CT systems. Their products aim to meet the clinical needs and workflow demands of diagnostic imaging departments […]

Siemens Medical Solutions USA, Inc., operating as Siemens Healthineers USA, is a prominent medical technology company with a rich history spanning over 175 years, dedicated to pioneering breakthroughs in healthcare. As a subsidiary of the global Siemens Healthineers AG, the company offers a comprehensive portfolio that is central to clinical decision-making across the entire healthcare […]

Siemens Healthineers is a leading global medical technology company that pioneers breakthroughs in healthcare. The company focuses on medical technology and diagnostics, offering a wide range of products including imaging systems, laboratory diagnostics, and advanced therapies. Their innovations aim to improve patient outcomes and make healthcare more accessible and sustainable. Siemens Healthineers has a strong […]

Samsung Medison Co. is a global medical equipment company specializing in diagnostic imaging devices, particularly ultrasound systems. Established in 1985, the company has become the largest manufacturer of ultrasound systems in Korea. Samsung Medison integrates advanced technologies, including information technology, video signal processing, semiconductors, and communication, into its medical equipment. This integration enables the development […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.